Navigation

Lastacaft

  • Generic Name: alcaftadine ophthalmic solution
  • Brand Name: Lastacaft

Lastacaft (Alcaftadine Ophthalmic Solution) side effects drug center

  • Related Drugs
  • Health Resources
  • Lastacaft Side Effects Center

    What Is Lastacaft?

    Lastacaft (alcaftadine) Ophthalmic Solution is an antihistamine used to prevent itching in the eyes caused by allergies.

    What Are Side Effects of Lastacaft?

    Common side effects of Lastacaft include:

    • mild and temporary burning/stinging/irritation of the eyes when you apply Lastacaft,
    • eye redness or itching,
    • runny or stuffy nose,
    • sore throat,
    • flu symptoms, or
    • headache.

    A very serious allergic reaction to Lastacaft is rare. Get medical help right away if you notice any symptoms of a serious allergic reaction, including: rash, itching or swelling (especially of the face/tongue/throat), severe dizziness, or trouble breathing.

    Dosage for Lastacaft

    The dose of Lastacaft is one drop instilled in each eye once daily.

    What Drugs, Substances, or Supplements Interact with Lastacaft?

    Lastacaft may interact with other drugs. Tell your doctor all medications and supplements you use.

    Lastacaft During Pregnancy and Breastfeeding

    During pregnancy, Lastacaft should be used only if prescribed. It is unknown if this drug passes into breast milk. Consult your doctor before breastfeeding.

    Additional Information

    Our Lastacaft (alcaftadine) Ophthalmic Solution Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.

     

    Lastacaft Consumer Information

    Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

    Stop using alcaftadine ophthalmic and call your doctor at once if you have severe burning, stinging, or other irritation after using the eye drops.

    Less serious side effects may include:

    • mild burning, stinging, or irritation;
    • eye redness or itching;
    • runny or stuffy nose, sore throat, flu symptoms; or
    • headache.

    This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

    Read the entire detailed patient monograph for Lastacaft (Alcaftadine Ophthalmic Solution)

     

    Lastacaft Professional Information

    SIDE EFFECTS

    Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in clinical practice.

    Clinical Studies Experience

    The most frequent ocular adverse reactions, occurring in less than 4% of eyes treated with LASTACAFT®, were eye irritation, burning and/or stinging upon instillation, eye redness and eye pruritus.

    Non-ocular Adverse Reactions

    The most frequent non-ocular adverse reactions, occurring in less than 3% of subjects with eyes treated with LASTACAFT®, were nasopharyngitis and headache. Some of these events were similar to the underlying disease being studied.

    Postmarketing Experience

    The following adverse reactions have been identified during postmarketing use of LASTACAFT® in clinical practice. Because they are reported voluntarily from a population of unknown size, estimates of frequency cannot be made. These reactions include eye discharge, eye swelling, erythema of eyelid, eyelid edema, lacrimation increased, vision blurred, hypersensitivity reactions including swelling of the face or allergic dermatitis, and somnolence.

    Read the entire FDA prescribing information for Lastacaft (Alcaftadine Ophthalmic Solution)

    &Copy; Lastacaft Patient Information is supplied by Cerner Multum, Inc. and Lastacaft Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.